Dr. Harold Varmus, director of the National Cancer Institute and Nobel Laureate, addressed a National Press Club Newsmaker Sept. 25.
Cancer research budgets have remained flat and legislative preference for specific cancers is a slippery slope, Varmus said. For example, the Pancreatic Cancer Research and Education Act passed by the House of Representatives might redirect funding from the Cancer Institute or earmark it for a specific cancer.
By using genomics the institute is moving closer to cures, Varmus said. He noted, however that specific cancers differ.